Keywords COPD NAFLD NASH Pharmacoeconomics budget impact analysis chemotherapy children clinical and economic analysis cost-effectiveness analysis cost-utility analysis direct costs health technology assessment indirect comparison multiple myeloma non-alcoholic fatty liver disease non-alcoholic steatohepatitis pharmacoeconomic analysis pharmacoeconomic modeling pharmacoeconomic studies pharmacoeconomics pharmacoepidemiology

Notifications

• View
• Subscribe